Skip to main content

Want a detailed portfolio tracker?

Abivax (ABVX) P/E (2023 - 2026)

Abivax (ABVX) P/E from Oct 20, 2023 to Jul 21, 2026. The TTM Abivax (ABVX) P/E is -15.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Abivax (ABVX)

YearP/EChange
2026-15.28+1.55%
2025-15.04+609.17%
2024-2.12+39.46%
2023-1.52N/A

Comparison Abivax (ABVX) P/E with competitors

Abivax (ABVX) P/E is -15.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.03%
ENLVEnlivex Ltd0.07-100.49%
FGENFibroGen Inc0.24-101.57%
CHRSCoherus Biosciences Inc0.85-105.55%
FBIOFortress Biotech Inc0.95-106.21%
ORMPOramed Pharmaceuticals Inc1.50-109.84%
AGENAgenus Inc3.01-119.70%
INVAInnoviva Inc3.15-120.65%
VXRTVaxart Inc3.55-123.24%
CRMDCorMedix Inc3.63-123.75%
CVACCureVac N.V.4.45-129.10%
GLPGGalapagos NV4.86-131.81%
SRPTSarepta Therapeutics Inc4.88-131.96%
ABEOAbeona Therapeutics Inc5.39-135.27%
ZVRAZevra Therapeutics Inc5.89-138.54%
SPROSpero Therapeutics Inc6.23-140.77%
CGENCompugen Ltd6.31-141.33%
RIGLRigel Pharmaceuticals6.87-144.98%
SLXNSilexion Therapeutics Corp7.30-147.76%
OMEROmeros Corporation9.26-160.61%
AUPHAurinia Pharmaceuticals Inc9.58-162.74%
PLXProtalix BioTherapeutics Inc10.89-171.29%
ACADAcadia Pharmaceuticals Inc11.73-176.77%
TBPHTheravance Biopharma Inc12.26-180.27%
ADMAAdma Biologics Inc12.42-181.29%
HRMYHarmony Biosciences Holdings Inc13.82-190.47%
SABSSAB Biotherapeutics Inc14.14-192.53%
NAGENiagen Bioscience Inc14.82-197.00%
INCYIncyte Corp15.82-203.57%
REGNRegeneron Pharmaceuticals Inc15.86-203.80%
PBYIPuma Biotechnology Inc17.32-213.35%
CPRXCatalyst Pharmaceuticals Inc17.44-214.16%
EXELExelixis Inc17.54-214.80%
TGTXTG Therapeutics Inc18.97-224.15%
MDXGMimedx Group Inc20.55-234.54%
XOMAXOMA Royalty Corp22.87-249.74%
ARGXArgen X SE24.30-259.06%
CTMXCytomX Therapeutics Inc24.82-262.48%
XOMAOXOMA Royalty Corp25.34-265.91%
HALOHalozyme Therapeutics Inc25.62-267.74%
XOMAPXOMA Royalty Corp25.67-268.04%
VRTXVertex Pharmaceuticals Inc27.99-283.26%
RPRXRoyalty Pharma plc - Class A28.69-287.79%
SLNOSoleno Therapeutics Inc29.02-289.94%
ASNDAscendis Pharma A/S30.09-296.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-348.18%
APLSApellis Pharmaceuticals Inc39.02-355.44%
BMRNBiomarin Pharmaceutical Inc42.21-376.32%
KRYSKrystal Biotech Inc45.34-396.82%
ONCBeiGene Ltd69.54-555.22%
PHARPharming Group N.V.75.03-591.12%
TECHBio-Techne Corp101.96-767.43%
VCELVericel Corp109.92-819.56%
ALNYAlnylam Pharmaceuticals Inc117.96-872.21%
GMABGenmab140.29-1018.36%
TLXTelix Pharmaceuticals Ltd162.15-1161.47%
CORTCorcept Therapeutics Inc212.86-1493.39%